Literature DB >> 25954496

The diagnosis and treatment of chronic migraine.

Mark W Weatherall1.   

Abstract

Migraine is the most common disabling brain disorder. Chronic migraine, a condition characterized by the experience of migrainous headache on at least 15 days per month, is highly disabling. Patients with chronic migraine present to primary care, are often referred for management to secondary care, and make up a large proportion of patients in specialist headache clinics. Many patients with chronic migraine also have medication overuse, defined as using a compound analgesic, opioid, triptan or ergot derivative on at least 10 days per month. All doctors will encounter patients with chronic headaches. A basic working knowledge of the common primary headaches, and a rational manner of approaching the patient with these conditions, allows a specific diagnosis of chronic migraine to be made quickly and safely, and by making this diagnosis one opens up a substantial number of acute and preventive treatment options. This article discusses the current state of management of chronic migraine.

Entities:  

Keywords:  chronic migraine; headache; medication overuse headache; migraine

Year:  2015        PMID: 25954496      PMCID: PMC4416971          DOI: 10.1177/2040622315579627

Source DB:  PubMed          Journal:  Ther Adv Chronic Dis        ISSN: 2040-6223            Impact factor:   5.091


  38 in total

1.  Who is referred to neurology clinics?--the diagnoses made in 3781 new patients.

Authors:  J Stone; A Carson; R Duncan; R Roberts; C Warlow; C Hibberd; R Coleman; R Cull; G Murray; A Pelosi; J Cavanagh; K Matthews; R Goldbeck; R Smyth; J Walker; M Sharpe
Journal:  Clin Neurol Neurosurg       Date:  2010-06-19       Impact factor: 1.876

2.  New appendix criteria open for a broader concept of chronic migraine.

Authors:  J Olesen; M-G Bousser; H-C Diener; D Dodick; M First; P J Goadsby; H Göbel; M J A Lainez; J W Lance; R B Lipton; G Nappi; F Sakai; J Schoenen; S D Silberstein; T J Steiner
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

3.  Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

Authors:  Stephen D Silberstein; Richard B Lipton; David W Dodick; Frederick G Freitag; Nabih Ramadan; Ninan Mathew; Jan L Brandes; Marcelo Bigal; Joel Saper; Steven Ascher; Donna M Jordan; Steven J Greenberg; Joseph Hulihan
Journal:  Headache       Date:  2007-02       Impact factor: 5.887

4.  Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria.

Authors:  P Zeeberg; J Olesen; R Jensen
Journal:  Cephalalgia       Date:  2008-09-24       Impact factor: 6.292

5.  Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study.

Authors:  Stewart J Tepper; Carl G H Dahlöf; Andrew Dowson; Lawrence Newman; Hank Mansbach; Martin Jones; Ba Pham; Chris Webster; Reijo Salonen
Journal:  Headache       Date:  2004-10       Impact factor: 5.887

6.  Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Authors:  H-C Diener; G Bussone; J C Van Oene; M Lahaye; S Schwalen; P J Goadsby
Journal:  Cephalalgia       Date:  2007-04-18       Impact factor: 6.292

7.  Imaging patients with suspected brain tumour: guidance for primary care.

Authors:  David P Kernick; Fayyaz Ahmed; Anish Bahra; Andrew Dowson; Giles Elrington; Manuela Fontebasso; Nicola J Giffin; Sue Lipscombe; Anne MacGregor; Richard Peatfield; Stuart Weatherby; Tom Whitmarsh; Peter J Goadsby
Journal:  Br J Gen Pract       Date:  2008-12       Impact factor: 5.386

8.  Premonitory symptoms in migraine: an electronic diary study.

Authors:  N J Giffin; L Ruggiero; R B Lipton; S D Silberstein; J F Tvedskov; J Olesen; J Altman; P J Goadsby; A Macrae
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

9.  Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks.

Authors:  Farooq Husain Maniyar; Till Sprenger; Teshamae Monteith; Christoph Schankin; Peter James Goadsby
Journal:  Brain       Date:  2013-11-25       Impact factor: 13.501

10.  Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation.

Authors:  Paolo Martelletti; Zaza Katsarava; Christian Lampl; Delphine Magis; Lars Bendtsen; Andrea Negro; Michael Bjørn Russell; Dimos-Dimitrios D Mitsikostas; Rigmor Højland Jensen
Journal:  J Headache Pain       Date:  2014-08-28       Impact factor: 7.277

View more
  37 in total

1.  The diagnosis and treatment of chronic migraine: the case for daily scheduled opioid treatment in chronic headache.

Authors:  Iraj Derakhshan
Journal:  Ther Adv Chronic Dis       Date:  2015-11       Impact factor: 5.091

2.  A Stereotyped Syndrome with Retro-Ocular Pain, Photophobia, and Visual Disturbance Masquerading as Optic Neuritis: Case Series.

Authors:  Joanna M Jefferis; Revelle Littlewood; Irene M Pepper; Simon J Hickman
Journal:  Neuroophthalmology       Date:  2018-08-15

Review 3.  Sex Differences in Chronic Migraine: Focusing on Clinical Features, Pathophysiology, and Treatments.

Authors:  Chia-Kuang Tsai; Chia-Lin Tsai; Guan-Yu Lin; Fu-Chi Yang; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2022-02-26

4.  Low Dose Naltrexone in Conjunction With the Wahls Protocol to Reduce the Frequency of Chronic Migraines in a Patient With Multiple Sclerosis: A Case Study.

Authors:  Heidi Codino; Angela Hardin
Journal:  Integr Med (Encinitas)       Date:  2021-06

5.  The Work of Workplace Disclosure: Invisible Chronic Conditions and Opportunities for Design.

Authors:  Kausalya Ganesh; Amanda Lazar
Journal:  Proc ACM Hum Comput Interact       Date:  2021-04

6.  Evaluation of serum uric levels in migraine.

Authors:  Tamer Yazar; Hülya Olgun Yazar; Ali Aygün; Volkan Karabacak; Yavuz Altunkaynak; Dursun Kirbaş
Journal:  Neurol Sci       Date:  2020-07-20       Impact factor: 3.307

7.  Migraine-Like Visual Auras Among Traumatized Cambodians with PTSD: Fear of Ghost Attack and Other Disasters.

Authors:  Devon E Hinton; Ria Reis; Joop de Jong
Journal:  Cult Med Psychiatry       Date:  2018-06

8.  Rhynchophylline attenuates migraine in trigeminal nucleus caudalis in nitroglycerin-induced rat model by inhibiting MAPK/NF-кB signaling.

Authors:  Tianbao Lai; Liangyi Chen; Xingyu Chen; Jianquan He; Peiyu Lv; Hua Ge
Journal:  Mol Cell Biochem       Date:  2019-08-16       Impact factor: 3.842

Review 9.  Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain.

Authors:  Adriana Della Pietra; Juha Savinainen; Rashid Giniatullin
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

10.  Phenome-wide analysis highlights putative causal relationships between self-reported migraine and other complex traits.

Authors:  Luis M García-Marín; Adrián I Campos; Nicholas G Martin; Gabriel Cuéllar-Partida; Miguel E Rentería
Journal:  J Headache Pain       Date:  2021-07-08       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.